These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 25634253)

  • 1. Novel urinary biomarkers in pre-diabetic nephropathy.
    Garg V; Kumar M; Mahapatra HS; Chitkara A; Gadpayle AK; Sekhar V
    Clin Exp Nephrol; 2015 Oct; 19(5):895-900. PubMed ID: 25634253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.
    Zeng XF; Lu DX; Li JM; Tan Y; Li Z; Zhou L; Xi ZQ; Zhang SM; Duan W
    BMC Nephrol; 2017 Jul; 18(1):233. PubMed ID: 28701152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of an earlier tubulopathy in diabetic nephropathy among children with normoalbuminuria.
    Hafez MH; El-Mougy FA; Makar SH; Abd El Shaheed S
    Iran J Kidney Dis; 2015 Mar; 9(2):126-31. PubMed ID: 25851291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
    Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
    Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
    Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
    Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as early markers of diabetic nephropathy.
    Siddiqi Z; Karoli R; Kaul A; Fatima J; Varshney S; Beg MS
    Ann Afr Med; 2017; 16(3):101-106. PubMed ID: 28671149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spot urine albumin to creatinine ratio outperforms novel acute kidney injury biomarkers in patients with acute myocardial infarction.
    Tziakas D; Chalikias G; Kareli D; Tsigalou C; Risgits A; Kikas P; Makrygiannis D; Chatzikyriakou S; Kampouromiti G; Symeonidis D; Voudris V; Konstantinides S
    Int J Cardiol; 2015 Oct; 197():48-55. PubMed ID: 26113474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.
    Papadopoulou-Marketou N; Skevaki C; Kosteria I; Peppa M; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Hormones (Athens); 2015; 14(2):232-40. PubMed ID: 25402375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.
    Bolignano D; Lacquaniti A; Coppolino G; Donato V; Fazio MR; Nicocia G; Buemi M
    Kidney Blood Press Res; 2009; 32(2):91-8. PubMed ID: 19321980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
    Nielsen SE; Schjoedt KJ; Astrup AS; Tarnow L; Lajer M; Hansen PR; Parving HH; Rossing P
    Diabet Med; 2010 Oct; 27(10):1144-50. PubMed ID: 20854382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study.
    Yang YH; He XJ; Chen SR; Wang L; Li EM; Xu LY
    Endocrine; 2009 Aug; 36(1):45-51. PubMed ID: 19390997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of coronary artery bypass graft surgery in diabetic and non-diabetic patients: a study with urinary neutrophil gelatinase-associated lipocalin and serum cystatin C.
    Arun O; Celik G; Oc B; Unlu A; Celik JB; Oc M; Duman A
    Kidney Blood Press Res; 2015; 40(2):141-52. PubMed ID: 25832128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatin-induced acute kidney injury better than albuminuria or urinary cystatin C levels.
    Lin HY; Lee SC; Lin SF; Hsiao HH; Liu YC; Yang WC; Hwang DY; Hung CC; Chen HC; Guh JY
    Kaohsiung J Med Sci; 2013 Jun; 29(6):304-11. PubMed ID: 23684135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes.
    Wu J; Shao X; Lu K; Zhou J; Ren M; Xie X; Liu J; Xu Y; Ding Y; Shen X; Zhu C
    Cell Physiol Biochem; 2017; 42(2):594-602. PubMed ID: 28954270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cystatin C and serum and urine NGAL in the kidney function assessment of patients with MGUS.
    Stelmach-Goldys A; Czarkowska-Paczek B; Wyczalkowska-Tomasik A; Paczek L
    Eur J Haematol; 2015 Feb; 94(2):162-8. PubMed ID: 25046079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL.
    Lacquaniti A; Donato V; Pintaudi B; Di Vieste G; Chirico V; Buemi A; Di Benedetto A; Arena A; Buemi M
    Acta Diabetol; 2013 Dec; 50(6):935-42. PubMed ID: 23754672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.